SYMBICORT is NOT a rescue medication and does NOT replace fast-acting inhalers to treat acute symptoms.
Mean percent change from baseline FEV1 was measured at day of randomization, months 6 and 12.3
Majority of FEV1 improvement at 5 minutes each time† in a subset of SUN Study patients taking SYMBICORT 160/4.5 (n=121)4
Significant lung function improvement with continuous control, as demonstrated over 12 months in the SUN Study (n=494)1,4
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.